Myotonic Dystrophy type 2 (DM2)
- Number 180
- Date 6 December 2010
6The ENMC consortium on myotonic dystrophy type 2, DM2, held its 5th workshop in Naarden, the Netherlands, 3-5th December 2010. It was attended by 19 active participants from Finland, France, Germany, Italy, The Netherlands, Czech republik, and the USA. Participants reported on the occurrence of DM2 in various countries indicating that the overall prevalence of symptomatic patients is very similar to that of DM1. At least in Finland and Czech republik the prevalence of DM2 is even higher than DM1 based on the numbers of genetically diagnosed patients. There is still a too long delay between onset of disease symptoms and final correct diagnosis due to insufficient awareness of DM2 among doctors and due to the large variation of symptoms and signs. Milder forms, the high frequency of muscle pain and abscence of clear myotonia in a large proportion of patients are some of the misleading factors deserving more attention. Exact molecular diagnosis is mandatory for the patients to have a correct understanding of their symptoms and for optimal management. DM2 is still underdiagnosed even in countries with good neuromuscular centers, which indicates that the treshold for requesting DNA-testing should be kept rather low than high. Increasing number of laboratories provide molecular diagnostic testing also in Central-Eastern European countries. Much of the efforts of the workshop focused on the scientific research to understand the abnormal events taking place in the muscles and other affected organs caused by the DM2 mutation. Progress has been made in the clarification of some of the molecular processes taking place in the cells. Many of these abnormalities have basic similarities with the molecular processes causing DM1, Steinert's disease. However, other DM2 specific and more complex abnormalities were also identified. The workshop agreed on guidelines for genetic testing and management of DM2 which will be included in the extended report of the meeting which is published in Neuromuscular Disorders (pdf).
ENMC
Lt. generaal van Heutszlaan 6
3743 JN BAARN
The Netherlands
+ 31- 35-5480481
enmc@enmc.org
We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.
If you do not want that we track your visit to our site you can disable tracking in your browser here:
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
The following cookies are also needed - You can choose if you want to allow them:
You can read about our cookies and privacy settings in detail on our Privacy Policy Page.
Privacy Policy